HopeStage
Back to all studies
CompletedNCT00043654

Mifepristone for depression in bipolarity

About this title

Clinical Trial of Mifepristone for Bipolar Depression

Read the official source — NCT00043654
Medication studyAges 18–75United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 75 years.

Listed locations
PhiladelphiaSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 7, 2002
Recruitment status
Completed
Enrollment listed in the registry
110
Sponsor
National Institute of Mental Health (NIMH)
Sponsor type
Government agency
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT00043654
Official title
Show the full official title

Antiglucocorticoid Therapy in Bipolar Depression With Mifepristone (RU486)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Philadelphia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute of Mental Health (NIMH), a government agency.

Did this study involve medication?

Yes. The study involved medication, including Mifepristone.

Who was this study for?

Listed age limits: 18 years to 75 years.

Want to explore more studies?

Explore studies